Aspen Aerogels Inc has a consensus price target of $36.07 based on the ratings of 15 analysts. The high is $70 issued by Benchmark on December 10, 2021. The low is $14 issued by Benchmark on March 20, 2023. The 3 most-recent analyst ratings were released by Craig-Hallum, Seaport Global, and Roth MKM on June 14, 2024, June 13, 2024, and June 12, 2024, respectively. With an average price target of $37.33 between Craig-Hallum, Seaport Global, and Roth MKM, there's an implied 58.87% upside for Aspen Aerogels Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/14/2024 | Buy Now | 61.7% | Craig-Hallum | Eric Stine | $33 → $38 | Maintains | Buy | Get Alert |
06/13/2024 | Buy Now | 61.7% | Seaport Global | Tom Curran | $31 → $38 | Maintains | Buy | Get Alert |
06/12/2024 | Buy Now | 53.19% | Roth MKM | Chip Moore | $28 → $36 | Reiterates | Buy → Buy | Get Alert |
06/05/2024 | Buy Now | 53.19% | TD Cowen | Jeffrey Osborne | $30 → $36 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | 53.19% | Piper Sandler | Alexander Potter | $30 → $36 | Maintains | Overweight | Get Alert |
05/14/2024 | Buy Now | 27.66% | Piper Sandler | Alexander Potter | $29 → $30 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | 19.15% | Canaccord Genuity | George Gianarikas | $18 → $28 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | 27.66% | B. Riley Securities | Christopher Souther | $24 → $30 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | 19.15% | Roth MKM | Chip Moore | $22 → $28 | Reiterates | Buy → Buy | Get Alert |
05/03/2024 | Buy Now | 23.4% | Piper Sandler | Alexander Potter | $20 → $29 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | 6.38% | HC Wainwright & Co. | Amit Dayal | $20 → $25 | Maintains | Buy | Get Alert |
04/30/2024 | Buy Now | -6.38% | Roth MKM | Chip Moore | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | Buy Now | -6.38% | Roth MKM | Chip Moore | → $22 | Initiates | → Buy | Get Alert |
02/14/2024 | Buy Now | -23.4% | Canaccord Genuity | George Gianarikas | $17 → $18 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | -14.89% | HC Wainwright & Co. | Amit Dayal | → $20 | Reiterates | Buy → Buy | Get Alert |
01/16/2024 | Buy Now | -14.89% | HC Wainwright & Co. | Amit Dayal | $30 → $20 | Maintains | Buy | Get Alert |
12/27/2023 | Buy Now | -27.66% | Canaccord Genuity | George Gianarikas | $13 → $17 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 27.66% | HC Wainwright & Co. | Amit Dayal | $45 → $30 | Maintains | Buy | Get Alert |
06/16/2023 | Buy Now | -40.43% | Canaccord Genuity | George Gianarikas | → $14 | Reiterates | Buy → Buy | Get Alert |
03/20/2023 | Buy Now | -40.43% | Benchmark | Subash Chandra | → $14 | Upgrade | Hold → Buy | Get Alert |
02/22/2023 | Buy Now | 2.13% | Piper Sandler | Alexander Potter | $33 → $24 | Maintains | Overweight | Get Alert |
02/17/2023 | Buy Now | -23.4% | Canaccord Genuity | George Gianarikas | $20 → $18 | Maintains | Buy | Get Alert |
12/13/2022 | Buy Now | 10.64% | B. Riley Securities | Christopher Souther | $39 → $26 | Maintains | Buy | Get Alert |
10/21/2022 | Buy Now | -14.89% | Canaccord Genuity | George Gianarikas | → $20 | Assumes | → Buy | Get Alert |
07/07/2022 | Buy Now | 36.17% | Craig-Hallum | Eric Stine | $50 → $32 | Maintains | Buy | Get Alert |
07/01/2022 | Buy Now | -23.4% | EF Hutton | Chip Moore | $48 → $18 | Maintains | Buy | Get Alert |
05/03/2022 | Buy Now | 36.17% | Canaccord Genuity | Jed Dorsheimer | $47 → $32 | Maintains | Buy | Get Alert |
04/29/2022 | Buy Now | 87.23% | B. Riley Securities | Thomas Curran | $59 → $44 | Maintains | Buy | Get Alert |
04/29/2022 | Buy Now | 104.26% | EF Hutton | Chip Moore | $55 → $48 | Maintains | Buy | Get Alert |
02/18/2022 | Buy Now | 189.36% | Piper Sandler | Alexander Potter | $72 → $68 | Maintains | Overweight | Get Alert |
02/18/2022 | Buy Now | 91.49% | HC Wainwright & Co. | Amit Dayal | $65 → $45 | Maintains | Buy | Get Alert |
12/10/2021 | Buy Now | 197.87% | Benchmark | Douglas Becker | — | Initiates | → Buy | Get Alert |
09/10/2021 | Buy Now | 146.81% | Piper Sandler | Alexander Potter | — | Initiates | → Overweight | Get Alert |
08/17/2021 | Buy Now | 117.02% | Oppenheimer | Colin Rusch | — | Initiates | → Outperform | Get Alert |
07/30/2021 | Buy Now | 91.49% | Canaccord Genuity | — | — | Maintains | Buy | Get Alert |
The latest price target for Aspen Aerogels (NYSE:ASPN) was reported by Craig-Hallum on June 14, 2024. The analyst firm set a price target for $38.00 expecting ASPN to rise to within 12 months (a possible 61.70% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for Aspen Aerogels (NYSE:ASPN) was provided by Craig-Hallum, and Aspen Aerogels maintained their buy rating.
The last upgrade for Aspen Aerogels Inc happened on March 20, 2023 when Benchmark raised their price target to $14. Benchmark previously had a hold for Aspen Aerogels Inc.
There is no last downgrade for Aspen Aerogels.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspen Aerogels, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspen Aerogels was filed on June 14, 2024 so you should expect the next rating to be made available sometime around June 14, 2025.
While ratings are subjective and will change, the latest Aspen Aerogels (ASPN) rating was a maintained with a price target of $33.00 to $38.00. The current price Aspen Aerogels (ASPN) is trading at is $23.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.